Main > A1. CORP. INDEX. A-Am No. 2 > Altamira Therapeutics Ltd. C2

---

This data is not available for free

Altamira Therapeutics Ltd. C2's subsections
2022. 05.23. PH FDA Approval
2022. 06.27. USA FDA Approval
2022. 11.30. HK Launch
2023. 02.27. Files Prov. Patent APP
2023. 11.10. EU Patent
2023. 11.17. Partial Spin-Off of
2024. 01.24. Files 2nd Prov Patent
web-site

Altamira Therapeutics Ltd. C2's products
This section has no products